Suggested remit - To appraise the clinical and cost effectiveness of SGT320 within its marketing authorisation for treating allergic rhinitis or rhinoconjunctivitis caused by house dust mites.
- Status:
- Awaiting development
- Technology type:
- Medicine
- Decision:
- None selected
- Process:
- TA
- ID number:
- 1278
Email enquiries
If you have any queries please email scheduling@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 27 February 2023 | Note added to the project documents |
| 21 June 2022 | Note added to the project documents |
| 15 March 2022 (10:00) | Scoping workshop |
| 20 January 2022 - 17 February 2022 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators |
For further information on our processes and methods, please see our CHTE processes and methods manual